NEU 4.15% $13.61 neuren pharmaceuticals limited

neu comparison vs other biotechs, page-2

  1. 16,463 Posts.
    lightbulb Created with Sketch. 774
    Down to $6.5m market cap , One can only keep accumulating in this environment.

    Intrepid - Phase II trial for TBI (fully funded)

    http://www.neurenpharma.com/ssl/CMS/files_cms/Arrowhead%20TBI%20Conference%20NNZ2566%20Presentation.pdf

    Motiva - Phase II trial for Post Stroke Apathy (fully funded)

    http://www.asx.net.au/asxpdf/20100303/pdf/31p1qnxh4rctvw.pdf

    Perseis - Currently selecting antibodies from preclinical trials (seeking collaboration to accelerate development)

    http://www.neurenpharma.com/ssl/CMS/files_cms/Perseis%20Overview%20Mar11.pdf
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$13.61
Change
-0.590(4.15%)
Mkt cap ! $1.739B
Open High Low Value Volume
$13.88 $13.91 $13.29 $13.29M 982.1K

Buyers (Bids)

No. Vol. Price($)
1 20000 $13.60
 

Sellers (Offers)

Price($) Vol. No.
$13.63 1000 1
View Market Depth
Last trade - 16.10pm 08/10/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.